- High insurance and overhead costs have closed many rural labor and delivery units, creating maternity deserts. Medscape Medical News
- Progression-free and overall survival outcomes in patients with cancer treated with immunotherapy could be related to thymic health. Medscape Medical News
- Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care. Medscape Medical News
- Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, high-risk early breast cancer, in the extended follow-up of a landmark trial. Medscape Medical News
- Data from a phase 3 study suggest that VER-01, a cannabis extract, provides sustained pain reduction for chronic low back pain vs placebo. Medscape Medical News
- "Diet" branding often obscures high‑calorie, low‑satiety foods that can derail patients' weight‑management plan. Medscape Medical News
- High insurance and overhead costs have closed many rural labor and delivery units, creating maternity deserts. Medscape Medical News
- Progression-free and overall survival outcomes in patients with cancer treated with immunotherapy could be related to thymic health. Medscape Medical News
- Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care. Medscape Medical News
- Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, high-risk early breast cancer, in the extended follow-up of a landmark trial. Medscape Medical News
- Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical exam of the future, and the problem of underpowered trials that even Bayesian analyses cannot rescue are the topics John Mandrola, MD, discusses in this week’s podcast. theheart.org on Medscape
- Dr Jiwon Oh reflects on the promise of new therapeutic strategies presented at ECTRIMS 2025. Medscape
RSS sorunu: A feed could not be found at `https://www.mayoclinic.org/rss/all-health-information-topics`; the status code is `200` and content-type is `text/html; charset=utf-8`
- A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 patients worldwide and was led by Cedars-Sinai researchers. Experts call it a game changer that’s likely to reshape treatment guidelines for aggressive […]
- A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the University of Florida and MD Anderson Cancer Center discovered that the vaccine’s immune-activating properties may boost cancer-fighting responses, acting like a nonspecific “flare” that reawakens the […]
- Researchers from NTNU and EPFL have unveiled a compact, low-cost laser that outperforms current models in speed, control, and precision. Built using microchip technology, it can be mass-produced for use in everything from Lidar navigation to gas detection. The design’s stability and easy frequency tuning could transform communication and sensing technologies.
- SuperAgers defy normal aging by keeping sharp memories and healthy brains well into their 80s. Northwestern scientists discovered that these individuals either resist the buildup of harmful brain proteins or remain unaffected by them. Their brains stay structurally youthful, and their strong social lives may help protect cognition. The findings could inspire new ways to […]
- Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the signal telling cancer cells to grow and divide. The treatment worked in mice with lung and breast tumors and didn’t cause harmful side effects seen in […]
- Researchers found that triple-negative breast cancer cells are “addicted” to lipids, a feature tied to obesity. By studying mice, they discovered that high lipid levels alone accelerate tumor growth. Lowering these fats slowed cancer progression, suggesting that lipid-lowering treatments could help. The findings also caution against high-fat diets such as keto for patients with obesity.
- Environmental Phenols and Growth in Infancy: The Infant Feeding and Early Development Studyhttps://pubmed.ncbi.nlm.nih.gov/38753668/
- Residential Proximity to Toxic Metal-emitting Industrial Sites and Toenail Metal Concentrations in a United States-wide Prospective Cohorthttps://pubmed.ncbi.nlm.nih.gov/38908662/
- Effects of Developmental Lead and Phthalate Exposures on DNA Methylation in Adult Mouse Blood, Brain, and Liver: A Focus on Genomic Imprinting by Tissue and Sexhttps://pubmed.ncbi.nlm.nih.gov/38833407/
- Coordinated DNA Polymerization by Polγ and the Region of LonP1 Regulated Proteolysishttps://pubmed.ncbi.nlm.nih.gov/38932681/
- Subchronic Inhalation Exposure to Ultrafine Particulate Matter Alters the Intestinal Microbiome in Various Mouse Modelshttps://pubmed.ncbi.nlm.nih.gov/38242419/
- Integrated Approach for Testing and Assessment for Developmental Neurotoxicity (DNT) To Prioritize Aromatic Organophosphorus Flame Retardantshttps://pubmed.ncbi.nlm.nih.gov/38922117/
- Data from a phase 3 study suggest that VER-01, a cannabis extract, provides sustained pain reduction for chronic low back pain vs placebo. Medscape Medical News
- Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows. Medscape Medical News
- A grip-strength study finds a link with obesity-related dysfunction and mortality. Should we all be squeezing stress balls? Medscape
- The proportion of physicians leaving clinical practice has increased since 2013. Medscape Medical News
- The position statement from cancer and bone societies updates recommendations from 2017 for managing bone loss and fracture risk linked to aromatase inhibitor use in hormone-sensitive breast cancer. Medscape Medical News
- A 70-year-old woman developed severe reflux oesophagitis and ulceration after months of semaglutide use, highlighting the potential gastrointestinal risks. Medscape UK